Summary
Intracerebroventricular neuropeptide Y (NPY) administration to normal rats for 7 days produced a sustained, threefold increase in food intake, resulting in a body weight gain of more than 40 g. Basal plasma insulin and triglyceride levels were increased in NPY-treated compared to vehicle-infused rats by about four- and two-fold, respectively. The glucose utilization index of white adipose tissue, measured by the labelled 2-deoxy-d-glucose technique was four times higher in NPY-treated rats compared to controls. This change was accompanied by an increase in the insulin responsive glucose transporter protein (GLUT 4). In marked contrast, muscle glucose utilization was decreased in NPY-treated compared to vehicle-infused animals. This change was accompanied by an increase in triglyceride content. When NPY-treated rats were prevented from overeating, there was no decrease in muscle glucose uptake, nor was there an increase in muscle triglyceride content. This suggests that muscle insulin resistance of ad libitum-fed NPY-treated rats is due to a glucose-fatty acid (Randle) cycle. When intracerebro-ventricular NPY administration was stopped and rats kept without any treatment for 7 additional days, all the abnormalities brought about by the neuropeptide were normalized. A tonic central effect of NPY is therefore needed to elicit and maintain most of the hormonal and metabolic abnormalities observed in the present study. Such abnormalities are analogous to those seen in the dynamic phase of obesity syndromes in which high hypothalamic NPY levels have been reported.
Article PDF
Similar content being viewed by others
Abbreviations
- NPY:
-
Neuropeptide Y
- icv:
-
intracerebroventricular
- GLUT 4:
-
glucose transporter 4
References
Jallut D, Golay A, Munger R et al. (1990) Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism. Metabolism 39: 1068–1075
Felber J-P (1992) From obesity to diabetes. Pathophysiological considerations. Int J Obes 16: 937–952
Pénicaud L, Kinebanyan MF, Ferré P et al. (1989) Development of VMH obesity: in vivo insulin secretion and tissue insulin sensitivity. Am J Physiol 257: E255–E260
Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF (1986) Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 7: 1189–1192
Pénicaud L, Ferré P, Terrettaz J et al. (1987) Development of obesity in Zucker rats. Early insulin resistance in muscles but normal sensitivity in white adipose tissue. Diabetes 36: 626–631
Stern JS, Johnson PR (1977) Spontaneous activity and adipose cellularity in the genetically obese Zucker rat (fa/fa). Metabolism 26: 371–380
Rohner-Jeanrenaud F, Jeanrenaud B (1985) Involvement of the cholinergic system in insulin and glucagon oversecretion of genetic preobesity. Endocrinology 116: 830–834
Pénicaud L, Ferré P, Assimacopoulos-Jeannet F et al. (1991) Increased gene expression of lipogenic enzymes and glucose transporter in white adipose tissue of suckling and weaned obese Zucker rats. Biochem J 279: 303–308
Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B (1993) Chronic intracerebroventricular Neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133: 1753–1758
Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B (1994) Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle. Diabetes 43: 764–769
Bchini-Hooft van Huijsduijnen O, Rohner-Jeanrenaud F, Jeanrenaud B (1993) Hypothalamic Neuropeptide Y messenger ribonucleic acid levels in pre-obese and genetically obese (fa/fa) rats; potential regulation thereof by corticotropin-releasing factor. J Neuroendocrinol 5: 381–386
Sanacora G, Finkelstein JA, White JD (1992) Developmental aspect of differences in hypothalamic preproneuropeptide Y messenger ribonucleic acid content in lean and genetically obese Zucker rats. J Neuroendocrinol 4: 353–357
Beck B, Burlet A, Bazin R, Nicolas JP, Burlet C (1993) Elevated Neuropeptide-Y in the arcuate nucleus of young obese Zucker rats may contribute to the development of their overeating. J Nutr 123 (6): 1168–1172
Chaouloff F, Jeanrenaud B (1988) Hyperinsulinemia of the genetically obese (fa/fa) rat is decreased by a low dose of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur J Pharmacol 147: 111–118
Rohner-Jeanrenaud F, Walker CD, Greco-Perotto R, Jeanrenaud B (1989) Central corticotropin-releasing factor administration prevents the excessive body weight gain of genetically obese (fa/fa) rats. Endocrinology 124: 733–739
Terrettaz J, Jeanrenaud B (1983) In vivo hepatic and peripheral insulin resistance in genetically obese (fa/fa) rats. Endocrinology 112: 1346–1351
Ferré P, Leturque A, Burnol AF, Pénicaud L, Girard J (1985) A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anesthetized rat. Biochem J 228: 103–110
James DE, Burleigh KM, Kraegen EW (1986) In vivo glucose metabolism in individual tissues of the rat. J Biol Chem 261: 6366–6374
Herbert V, Lau KS, Gottlieb CW, Bleicher SJ (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol 25: 1375–1384
Klip A, Ramlal T, Young DA, Holloszy JO (1987) Insulin-induced translocation of glucose transporters in rat hindlimb muscles. FEBS Lett 224: 224–230
Le Marchand-Brustel Y, Olichon-Berthe C, Gremeaux T, Tanti JF, Rochet N, van Obberghen E (1990) Glucose transporters in insulin sensitive tissues of lean and obese mice. Effects of the thermogenic agent BRL 26830A*. Endocrinology 127: 2687–2695
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277: 680–685
Haspel HC, Birnbaum MJ, Wilk EW, Rosen OM (1985) Biosynthetic precursors and in vitro translation products of human hepatocarcinoma cells, human fibroblasts and murine preadipocytes. J Biol Chem 260: 7219–7225
James DE, Strube M, Mueckler M (1989) Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 338: 83–87
Storlien LH, Jenkins AB, Chisholm DJ et al. (1991) Influence of dietary fat composition on development of insulin resistance in rats. Diabetes 40: 280–289
Akabayashi A, Wahlestedt C, Alexander JT, Leibowitz SF (1994) Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion. Mol Brain Res 21: 55–61
Cusin I, Terrettaz J, Rohner-Jeanrenaud F, Jeanrenaud B (1990) Metabolic consequences of hyperinsulinaemia imposed on normal rats on glucose handling by white adipose tissue, muscles and liver. Biochem J 267: 99–103
Cusin I, Rohner-Jeanrenaud F, Terrettaz J, Jeanrenaud B (1992) Hyperinsulinemia and its impact on obesity and insulin resistance. Int J Obes 16 [Suppl 4]: S1-S11
Randle PJ, Hales CN, Garland PB, Newsholm EA (1963) The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785–789
Felber J-P, Acheson KJ, Tappy L (1993) Obesity and lipid metabolism. In: Felber J-P, Acheson KJ, Tappy L (eds) From obesity to diabetes. John Wiley, pp 107–121
Dagenais GR, Tancredi RG, Zierler KL (1976) Free fatty acid oxidation by forearm muscle at rest, and evidence for an intramuscular lipid pool in the human forearm. J Clin Invest 58: 421–431
Groop LC, Bonadonna RC, Shank M, Petrides AS, DeFronzo RA (1991) Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. J Clin Invest 87: 83–89
Bringolf M, Zaragoza N, Rivier D, Felber J-P (1972) Studies on the metabolic effects induced in the rat by a high-fat diet: inhibition of pyruvate metabolism in diaphragm in vitro and its relation to oxidation of fatty acids. Eur J Biochem 26: 360–367
Schindler C, Felber J-P (1986) Study on the effect of a high-fat diet on diaphragm and liver glycogen and glycerides in the rat. Horm Metab Res 18: 91–93
Kiens B, Essen-Gustavson B, Gad P, Lithell H (1987) Lipoprotein lipase activity and intramuscular triglyceride stores after long-term high-fat and high carbohydrate diets in physically trained men. Clin Physiol 7: 1–9
Storlien LH, Oakes ND, Pan DA, Kusunoki M, Jenkins AB (1993) Syndromes of insulin resistance in the rat. Inducement by diet and amelioration with Benfluorex. Diabetes 42: 457–462
Takao F, Laury M-C, Ktorza A, Picon L, Pénicaud L (1990) Hyperinsulinemia increases insulin action in vivo in white adipose tissue but not in muscles. Biochem J 272: 255–257
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vettor, R., Zarjevski, N., Cusin, I. et al. Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia 37, 1202–1208 (1994). https://doi.org/10.1007/BF00399793
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00399793